864154-25-6

Basic information

• Product Name: ethanol
• Synonyms: ethanol
• CAS NO: 864154-25-6
• Molecular Weight: 208.257
• Mol File: 864154-25-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: ethanol(CAS DataBase Reference)
• NIST Chemistry Reference: ethanol(864154-25-6)
• EPA Substance Registry System: ethanol(864154-25-6)

Safety Data

• Hazardous Substances Data: 864154-25-6(Hazardous Substances Data)

Upstream product

• 36076-20-7 diethyl 2,2'-(1,3-phenylene)diacetate 
• 19806-17-8 1,3-benzenediacetic acid 
• 113520-28-8 2-(3-(2-ethoxy-2-oxoethyl)phenyl)acetic acid 
• 14062-30-7 ethyl 2-(3-bromophenyl)acetate 
• 1878-67-7 3-Bromophenylacetic acid 
• 272130-45-7 m-ethenylphenylacetic acid ethyl ester 

Downstream Products

• 864154-27-8 ethanol 
• 864154-24-5 ethanol 
• 1439400-22-2 ethanol 
• 1439400-23-3 ethanol 
• 1439395-97-7 C₃₃H₃₉N₇O₄S 
• 1439396-45-8 C₃₀H₃₃N₇O₃S 
• 950503-23-8 {2-[3-(2-hydroxy-ethyl)-phenyl]-ethyl}-(2-methoxy-ethyl)-carbamic acid tert-butyl ester 
• 950503-22-7 (3-{2-[tert-butoxycarbonyl-(2-methoxy-ethyl)-amino]-ethyl}-phenyl)-acetic acid ethyl ester 
• 864154-26-7 ethanol 

Relevant articles and documents

HETEROCYCLIC INHIBITORS OF GLUTAMINASE

The invention relates to the heterocyclic compounds of Formula (I) as defined further herein, and pharmaceutical preparations thereof. The invention further relates to methods of treating cancer, immunological or neurological diseases using the heterocyclic compounds of the invention.

AMP deaminase inhibitors. 3. SAR of 3-(carboxyarylalkyl)coformycin aglycon analogues

N3-Substituted coformycin aglycon analogues with improved AMP deaminase (AMPDA) inhibitory potency are described. Replacement of the 5-carboxypentyl substituent in the lead AMPDA inhibitor 3-(5-carboxypentyl)-3,6,7,8- tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol (2) described in the previous article with various carboxyarylalkyl groups resulted in compounds with 10- 100-fold improved AMPDA inhibitory potencies. The optimal N3 substituent had m-carboxyphenyl with a two-carbon alkyl tether. For example, 3-[2-(3-carboxy- 5-ethylphenyl)ethyl]-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol (43g) inhibited human AMPDA with a K(i) = 0.06 μM. The compounds within the series also exhibited > 1000-fold specificity for AMPDA relative to adenosine deaminase.